Investing Profile

Julie Sunderland

VC
Seattle, Washington
Photo of Julie Sunderland, Managing Director at Biomatics Capital Partners
cb
Biomatics Capital Partners Managing Director
$5.0M - $20.0M
$5.0M
2
$300M
CompanyStageDateRound SizeTotal Raised
BlackThorn Therapeutics
Series BJun 2019$76M
Series AJan 2017$14M
$130M
Co-investors: Brian Chee (Polaris Partners), Paul Berns (ARCH Venture Partners), Lori Hu (Vertex Ventures)